IL6 and Alzheimer disease: Interestingly, given that increased basal IL-6 levels in plasma have been shown to be a risk for decline in cognitive functions (73), as well as being described as one the most powerful predictors of morbidity and mortality in the elderly (30), these results suggest the possibility of using peripheral IL-6 production as a helpful tool to characterize immune dysfunction during AD progression.